Dyne, Avidity Initiated at Outperform by RBC on DM1 Drugs
Express News | PepGen Reports Inducement Grant Under Nasdaq Listing Rule 5635(C)(4) to Newly Appointed Senior Vice President, Clinical Development
PepGen Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) to Newly Appointed Senior Vice President, Clinical Development
Roku To Rally Around 31%? Here Are 10 Top Analyst Forecasts For Monday
B of A Securities Maintains Neutral on PepGen, Lowers Price Target to $6
PepGen Inc. (PEPG) Receives a Buy From Stifel Nicolaus
PepGen Is Maintained at Outperform by Wedbush
Express News | PepGen Inc : Wedbush Cuts Target Price to $12 From $19
H.C. Wainwright Maintains PepGen(PEPG.US) With Buy Rating, Maintains Target Price $26
Analysts Are Bullish on Top Healthcare Stocks: PepGen Inc. (PEPG), Ligand Pharma (LGND)
HC Wainwright & Co. Reiterates Buy on PepGen, Maintains $26 Price Target
PepGen Analyst Ratings
PepGen GAAP EPS of -$0.66 Beats by $0.21
PepGen Shares Are Trading Lower. The Company Reported Q3 Financial Results.
PepGen | 10-Q: Q3 2024 Earnings Report
PepGen | 8-K: PepGen Reports Third Quarter 2024 Financial Results and Recent Corporate Highlights
Express News | PepGen Qtrly Share Loss $0.66
Express News | PepGen Q3 Operating Expenses USD 23.171 Million
Express News | PepGen Q3 Net Income USD -21.384 Million
Press Release: PepGen Reports Third Quarter 2024 Financial Results and Recent Corporate Highlights